| |
|
|
Percutaneous
Electrical Nerve
Stimulation In The Treatment Of Irritable
Bowel Syndrome: A Case Report
Gerald W. Grass, MD
Abstract
Background A growing number of research findings indicate that
dysregulation of the autonomic nervous system may play a major role
in the development and perpetuation of irritable bowel syndrome (IBS)
symptoms. Recently, several reports have demonstrated that percutaneous
electrical nerve stimulation (PENS) of spinal or peripheral nerves alleviated
symptoms in other conditions believed to arise from autonomic nervous
system dysfunction.
Objective To illustrate the use of Craig-PENS in the treatment
of IBS symptoms.
Design, Setting, and Patient A case report of a patient with
a 16-year history of diarrhea-type IBS symptoms.
Intervention The patient was treated with Craig-PENS in a standard
arc pattern with points at T9, T12, L3, L5, and S3.
Main Outcome Measure State of IBS symptoms following treatment.
Results Following 15 treatment sessions, the patient reported
dramatic and long-lasting diminution of symptoms.
Conclusion The case reported herein suggests that Craig-PENS
is a promising therapeutic modality for the treatment of IBS symptoms
in those individuals with diarrhea-type patterns.
KEY WORDS
Craig-PENS, Irritable Bowel Syndrome, Percutaneous Electrical Nerve
Stimulation, Autonomic Dysfunction, Neuromodulation
INTRODUCTION
Irritable bowel syndrome (IBS) represents a constellation of symptoms
including abdominal cramping, bloating, constipation, and/or diarrhea
as well as multiple extra-intestinal symptoms. This syndrome affects
approximately 10%-15% of the US population.1 The economic impact of
this disease is estimated at $41 billion in direct health care
expenditures in the 8 most industrialized countries worldwide.2
Although the exact etiology of IBS remains unclear, a number of research
reports have demonstrated disordered central and autonomic nervous system
function in subgroups of patients with IBS. These studies point to a
generally decreased parasympathetic outflow or increased sympathetic
activity in conditions usually associated with decreased gastrointestinal
motility, while other studies have found either increased cholinergic
activity or decreased sympathetic activity in patients with symptoms
compatible with increased motor activity.3 In addition, autonomic dysfunction
may represent the physiological pathway accounting for many of the extra-intestinal
symptoms seen in patients with IBS, such as chronic fatigue, bladder
dysfunction, and myofascial pain.4
While various treatment modalities have been used in an attempt to ameliorate
the symptoms of IBS, including traditional pharmaceuticals, hypnotherapy,5,6
Chinese herbs,7 cognitive therapy,8 and biofeedback,9 few studies have
focused on direct stimulation of the autonomic nervous system in an
attempt to overcome colonic dysfunction.10-12
Recently, several studies have focused on a form of neuromodulation
known as percutaneous electrical nerve stimulation (PENS). PENS has
been shown to be an effective treatment in several conditions, including
low back pain and sciatica,13,14 headaches,15 bone pain from metastatic
cancer,16 and diabetic neuropathy.17 In addition, recent reports
have demonstrated that percutaneous electrical stimulation of spinal
or peripheral nerves can alleviate symptoms in other conditions believed
to arise from autonomic nervous system dysfunction, such as urinary
incontinence due to detrusor overactivity.18-20
My hypothesis was that a similar beneficial effect might be achieved
in patients with IBS. Current evidence suggests an autonomic nervous
system dysfunction in the pathogenesis of IBS symptoms. Thus, Craig-PENS
was chosen as treatment for this case.
CASE REPORT
A 48-year-old woman was referred from her primary care physician for
assistance with IBS symptoms. She developed symptoms in 1983, including
increasing episodes of explosive diarrhea, abdominal pain and bloating,
cramps, and recurring episodes of cystitis.
Over the preceding 16-year period, numerous specialists at a local community
and university hospital had evaluated her complaints with a battery
of diagnostic tests. In addition to routine laboratory studies including
complete blood cell count, SMA 12 (blood chemistry panel), fecal analysis,
food and environmental allergy testing, and thyroid studies, she had
undergone upper and lower gastrointestinal series, gastric motility
studies, colonoscopy, cystoscopy, intravenous pyelography, pelvic sonography,
computed tomography, and laparoscopy. No pathology was ever noted and
she was subsequently diagnosed as having IBS.
The patient reported that her symptoms frequently interfered with daily
activities and she could not travel far from home due to recurrent bouts
of diarrhea. In 1990, her symptoms became so intense that she underwent
a trial of bowel rest for 3 months; a Groshung catheter
was inserted for hyperalimentation. This treatment provided little symptomatic
relief and she continued to have frequent episodes of diarrhea.
At presentation, the patient indicated that she had an average of 3-4
days per week when she experienced 10-12 episodes of diarrhea per day
as documented in her daily journal, with more frequent episodes occurring
under emotional stress.
Her medical history was significant for a tonsillectomy in 1953, cholecystectomy
in 1983, and right mastectomy for breast cancer in 1990. She reported
no history of any other medical or psychiatric problems. Her medications
included dicyclomine, 20 mg 4 times per day, and acetaminophen-propoxyphene,
1 tablet every 4 hours as needed. She had been given trials of antidepressants,
narcotic analgesics, and other antispasmodics over the years without
appreciable benefit. In addition, she had used numerous over-the-counter
and nutritional supplements as well as various restrictive dietary regimens
in an attempt to alleviate her symptoms, all without significant relief.
Physical examination was remarkable only for well-healed incisions from
the previous surgical procedures and multiple tender myofascial bands
noted in the paravertebral areas bilateral to the T9 to S3 spinous processes.
After an explanation of the risks and potential benefits, the patient
consented to a trial of Craig-PENS therapy for the IBS symptoms. She
was asked to continue to daily record her physical symptoms and number
of bowel movements.
TREATMENT
The treatment modality used in this case was Craig-PENS. This technique
was originated by William F. Craig, MD13-17,21 who developed this modality
in the late 1970s as an acupuncture-like method of PENS
for the treatment of pain. It involves the placement of thin stainless
steel acupuncture needles through the skin into muscles and nerves related
to the dermatomes, myotomes, or sclerotomes based on the segmental pattern
of nerve distribution thought to be involved in the underlying pathology.
A microcurrent electrical stimulator is then attached to the needles
in a prescribed pattern, known as a montage, and then set to stimulate
the chosen points for a specified frequency, intensity, and duration.
These variables are recorded and adjusted at each treatment session,
depending on the patients clinical response to the previous session.
In this case, prior to the beginning of each treatment session, the
patients daily journal was reviewed and her progress assessed
to determine the appropriate treatment frequency.
The patient was placed in a prone position on the treatment table and
10 32-gauge, 60-mm Seirin L type (Seirin-Kasei Co, Shimizu
City, Japan) acupuncture needles were inserted bilaterally at 1.5 cm
lateral to the inferior tip of the T9, T12, L3, L5, and S3 spinous processes
to a depth of approximately 2-3 cm. Insertion points T9, T12, L3, and
L5 were chosen due to the presence of tender myofascial bands at those
levels, as well as their known contribution to various autonomic ganglia
involved in gastrointestinal regulation. The insertion point S3 was
added in an attempt to help alleviate the patients symptoms of
recurring cystitis.22
No attempt was made to elicit the traditional De Qi sensation during
needle insertion; the needles were not manipulated or twirled following
insertion. A microcurrent generator (AWQ-104 Series; OMS Medical Supplies,
Braintree, Mass) with an asymmetric biphasic waveform pattern, a pulse
width of 400 milliseconds, and a continuous duty cycle was used to stimulate
the electrodes. Prior to each treatment session, the microcurrent generator
was calibrated using a digital multimeter (Kaito MY66; Kaito Electronics,
Walnut, Calif) and then connected to the percutaneous electrodes in
a standard arc pattern according to the Craig-PENS protocol (Figure
1). The probes were stimulated for 30 minutes at each treatment session
with an initial frequency of 4 Hz and current settings of 20 mA.
The patient received 15 consecutive treatments, 1 each week for 15 weeks
over a 4-month period. The current settings remained constant on all
treatment sessions. Frequency settings were increased to 8 Hz on the
3rd session and
maintained at that frequency for all subsequent sessions.
RESULTS
The patient reported beneficial effects following the 2nd treatment
session: the number of diarrhea episodes had diminished to 3-5 per day,
with bouts occurring 3 times per week, and the abdominal pain of the
past 2-3 years had that she had had for the past 2-3 years had receded.
At that point, the input frequency was increased to 8 Hz, according
to the Craig-PENS protocol, to investigate any additional improvement.
After the 5th treatment session, the patient reported that the frequency
of diarrhea episodes had been reduced to 3-4 episodes per day, 1-2 times
per week and she reported feeling physically and psychologically healthier.
A minor setback in the patients progress was noted following the
9th session. During the week following that session, she indicated experiencing
extreme stress; she reported 15 diarrhea bowel movements after a particularly
stressful day. However, by the time of her 10th session, her bowel action
had been reduced to 1-2 episodes per day, 1-2 days per week.
The patients progress quickly resumed and by the 15th session,
she described only 1 diarrhea episode in the previous 3 weeks and had
discontinued all of her medications. She then began a maintenance schedule
of 1 treatment session every 3 months; she has been followed for an
additional 18 months as of this writing. The patient continues to maintain
her improvement and has reported only 2 recurrences of the diarrhea.
In addition, she also stated that the frequent episodes of cystitis
have not troubled her in the last 18 months. The overall results of
her treatment sessions are summarized in Figure 2.
 |
Figure 2. Diarrheal
Symptoms During Treatment with Craig-PENS*
* PENS indicates percutaneous electrical nerve stimulation. |
There were
no adverse effects attributable to the Craig-PENS therapy noted at any
time during or after the treatment sessions. Craig-PENS patients may
experience rebound periods during which the painful symptoms
become worse for several days. Since this treatment was not for a primarily
painful condition, a rebound was not expected and none was reported
by the patient.
DISCUSSION
While the exact etiology of IBS remains elusive, recently published
research findings indicate that dysregulation of the autonomic nervous
system may play a major role in the development and perpetuation of
symptoms.23-26 These reports point to generally increased cholinergic
activity or decreased sympathetic activity in patients with symptoms
compatible with increased colonic motor activity (as seen in this case).
However, no attempt was made to differentiate between parasympathetic
hyperactivity and sympathetic hypoactivity in this patient.
The Craig-PENS technique generally uses a progression of electrical
frequencies adjusted to the patients response. The regimen usually
involves a frequency sequence of low (2-4 Hz), intermediate (15-30 Hz),
high (100 Hz), and then back to low (4-6 Hz). The rationale for this
progression is based on preliminary studies conducted by Dr Craig, who
found this progression effective. Recently, however, Dr Craig and his
group have called these findings into question and are attempting to
determine which frequency or combination of frequencies is optimal for
specific conditions.21 (Considering this fact, when the patient requested
that the stimulus frequency be held at 8 Hz, given her dramatic response
to the treatment, it was believed at that point that improvement on
her current level of progress could not be effected and therefore, deferral
to her request was made. Whether some additional benefit may have been
achieved by following the standard protocol is unknown and may be a
fruitful area for further investigation.)
Although the exact mechanism of action of Craig-PENS is unknown, the
improvement caused by this form of neuronal stimulation may be due to
a resetting of 1 or several of the parallel neuronal feedback
systems involved in the regulation of gut motility. Although a review
of the autonomic and enteric innervation of the gastrointestinal system
is
beyond the scope of this report, this effect may occur centrally and/or
peripherally because recent evidence suggests that the peripheral endings
of sensory neurons are involved in vasodilatation, increases in vascular
permeability, contraction and relaxation of smooth muscle, and depolarization
of autonomic efferent neurons in the prevertebral ganglia.3 It is therefore
possible that electrical stimulation of spinal nerves may not only stimulate
cord, medullary, and higher brain centers to effect change, but also
may spread in an antidromic fashion to modify local reflex arcs regulating
gastrointestinal tract homeostasis.
CONCLUSION
Craig-PENS appears to be a promising therapeutic modality for the treatment
of IBS symptoms in those individuals with diarrhea-type patterns. The
technique is minimally invasive, requires only 30 minutes per week,
and in this case, was not associated with adverse effects or safety
issues. It is hoped that this report will encourage other clinicians
who are treating patients with IBS to try this procedure and report
their findings to help determine the overall applicability of this treatment
in IBS.
REFERENCES
-
Camilleri
M. Management of the irritable bowel syndrome. Gastroenterology.
2001;120:652-668.
-
Camilleri
M, Williams DE. Economic burden of irritable bowel syndrome: proposed
strategies to control expenditures. Pharmacoeconomics. 2000;17:331-338.
-
Mayer
EA, Raybould HE. Role of visceral afferent mechanisms in functional
bowel disorders. Gastroenterology. 1990;99:1688-1704.
-
Sperber
AD, Atzman Y, Neumann L, et al. Fibromyalgia in the irritable bowel
syndrome: studies of prevalence and clinical implications. Am J
Gastroenterol. 1999;94:3541-3546.
-
Galovski
TE, Blanchard EB. The treatment of irritable bowel syndrome with
hypnotherapy. Appl Psychophysiol Biofeedback. 1998;23: 219-232.
-
Vidakovic-Vukic
M. Hypnotherapy in the treatment of irritable bowel syndrome: methods
and results in Amsterdam. Scand J Gastroenterol Suppl. 1999;230:49-51.
-
Wong
HC, Wong JK, Wong NY. Chinese herbal medicine for irritable bowel
syndrome. JAMA. 1999;282:1036-1037.
-
Boyce
P, Gilchrist J, Talley NJ, Rose D. Cognitive-behaviour therapy as
a treatment for irritable bowel syndrome: a pilot study. Aust N
Z J Psychiatry. 2000;34:300-309.
-
Whitehead
WE. Biofeedback treatment of gastrointestinal disorders. Biofeedback
Self Regul. 1992;17:59-76.
-
Chan J,
Carr I, Mayberry JF. The role of acupuncture in the treatment of
irritable bowel syndrome: a pilot study. Hepatogastroenterology.
1997;44:
1328-1330.
-
Diehl
DL. Acupuncture for gastrointestinal and hepatobiliary disorders.
J Altern Complement Med. 1999;5:27-45.
-
Kunze
M, Seidel HJ, Stube G. Comparative studies of the effectiveness
of brief psychotherapy, acupuncture and papaverin therapy in patients
with irritable bowel syndrome [in German]. Z Gesamte Inn Med. 1990;45:625-627.
-
Ghoname
EA, Craig WF, White PF, et al. Percutaneous electrical nerve stimulation
for low back pain: a randomized crossover study. JAMA. 1999;281:818-823.
-
Ghoname
EA, White PF, Ahmed HE, et al. Percutaneous electrical nerve stimulation:
an alternative to TENS in the management of sciatica. Pain. 1999;83:193-199.
-
Ahmed
HE, et al. Use of percutaneous electrical nerve stimulation (PENS)
in the short-term management of headache. Headache. 2000;40:311-315.
-
Ahmed
HE, Craig WF, White PF, Huber P. Percutaneous electrical nerve stimulation
(PENS): a complementary therapy for the management of pain secondary
to bony metastasis. Clin J Pain. 1998;14:320-323.
-
Hamza
MA, White PF, Craig WF, et al. Percutaneous electrical nerve stimulation:
a novel analgesic therapy for diabetic neuropathic pain. Diabetes
Care. 2000;23:365-370.
-
Lewey
J, Lilas L. Electrical stimulation of the overactive bladder. Prof
Nurse. 1999;15:211-214.
-
Brubaker
L. Electrical stimulation in overactive bladder. Urology. 2000;55(5A
Suppl):17-23.
-
Govier
FE, Litwiller S, Nitti V, Kreder KJ Jr, Rosenblatt P. Percutaneous
afferent neuromodulation for the refractory overactive bladder:
results of a multicenter study. J Urol. 2001;165:1193-1198.
-
Ghoname
E, Craig WF, White PF, et al. The effect of stimulus frequency on
the analgesic response to percutaneous electrical nerve stimulation
in patients with chronic low back pain. Anesth Analg. 1999;88:841-846.
-
Costa
JA, Kreder KJ. Spinal cord neuromodulation for voiding dysfunction.
Clin Obstet Gynecol. 2000;43:676-688.
-
Drossman
DA. Review article: an integrated approach to the irritable bowel
syndrome. Aliment Pharmacol Ther. 1999;13(Suppl 2):3-14.
-
Heitkemper
M, Burr RL, Jarrett M, et al. Evidence for autonomic nervous system
imbalance in women with irritable bowel syndrome. Dig Dis Sci. 1998;43:2093-2098.
-
Tougas
G. The autonomic nervous system in functional bowel disorders. Can
J Gastroenterol. 1999;13(Suppl A):15A-17A.
-
Wood JD.
Neuropathy in the brain-in-the-gut. Eur J Gastroenterol Hepatol.
2000;12:597-600.
AUTHOR
INFORMATION
Dr Gerald W. Grass is Board-certified in Emergency Medicine, and is
a Diplomat of the American Board of Medical Acupuncture and the American
Academy of Pain Management. He is a Fellow of the Association of Emergency
Physicians, and is currently in private practice specializing in Medical
Acupuncture and Pain Management.
Gerald W. Grass, MD, DABMA
8874 Lovers Lane Rd
Corfu, NY 14036
Phone: 716-599-3594 E-mail: gwgrass@hotmail.com
|
|
|
|